ConductScience.org, home

Paper8097006

Childbearing, oral contraceptive use, and breast cancer.

Beral V and 1 other. Lancet, 1993. Cited by 21 papers, by iCite.

Cite this record

ConductScience Library. Childbearing, oral contraceptive use, and breast cancer. Papers, record 8097006. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8097006

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Childbearing, oral contraceptive use, and breast cancer.
PubMed
Journal
Lancet
PubMed
Year
1993
PubMed
Publication types
Letter
PubMed
Citations, by iCite
21
iCite
Relative citation ratio, by iCite
0.53
iCite
Revised in PubMed
2019-06-11
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Beral VV
2Reeves GG

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Contraceptives, OralMajor topic
ParityMajor topic
Adult
Age Factors
Female
Humans
Middle Aged
Pregnancy

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in8099688Childbearing, oral contraceptive use, and breast cancer.https://conductscience.org/library/papers/8099688

Source PubMed

Download CSV of comments and corrections

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.

PMIDTitleJournalYearIn PapersSource
31083383Gene Expression and miRNAs Profiling: Function and Regulation in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer.Cancers (Basel)2019https://conductscience.org/library/papers/31083383PubMed
28114999Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program.Breast Cancer Res2017https://conductscience.org/library/papers/28114999PubMed
26615183The utility of web mining for epidemiological research: studying the association between parity and cancer risk.J Am Med Inform Assoc2016https://conductscience.org/library/papers/26615183PubMed
22762150Variation in breast cancer risk associated with factors related to pregnancies according to truncating mutation location, in the French National BRCA1 and BRCA2 mutations carrier cohort (GENEPSO).Breast Cancer Res2012https://conductscience.org/library/papers/22762150PubMed
21413009Circulating estrogens and progesterone during primiparous pregnancies and risk of maternal breast cancer.Int J Cancer2012https://conductscience.org/library/papers/21413009PubMed
18317955The present and the future of breast cancer burden in the Kingdom of Saudi Arabia.Med Oncol2008https://conductscience.org/library/papers/18317955PubMed
17311016Absence of the common Insulin-like growth factor-1 19-repeat allele is associated with early age at breast cancer diagnosis in multiparous women.Br J Cancer2007https://conductscience.org/library/papers/17311016PubMed
17187672Parity and breast cancer risk among BRCA1 and BRCA2 mutation carriers.Breast Cancer Res2006https://conductscience.org/library/papers/17187672PubMed
16622123Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS).J Natl Cancer Inst2006https://conductscience.org/library/papers/16622123PubMed
15756256
Insulin-like growth factor-1 (IGF1) genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating IGF-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families.
Br J Cancer2005https://conductscience.org/library/papers/15756256PubMed
15604634The decision to test in women receiving genetic counseling for BRCA1 and BRCA2 mutations.J Genet Couns2004https://conductscience.org/library/papers/15604634PubMed
12927042BRCA2 mutation carriers, reproductive factors and breast cancer risk.Breast Cancer Res2003https://conductscience.org/library/papers/12927042PubMed
7640237Recent trends in incidence of and mortality from breast, ovarian and endometrial cancers in England and Wales and their relation to changing fertility and oral contraceptive use.Br J Cancer1995https://conductscience.org/library/papers/7640237PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8097006

GET https://conductscience.org/api/papers/v1/8097006/authors